Background Remdesivir is widely used for treatment of SARS-CoV-2 pneumonia. The aim of
this study was to evaluate the characteristics of patients with moderate-to-severe COVID-19 …

Objective Controversial results on remdesivir efficacy have been reported. We aimed to
report our real-life experience with the use of remdesivir from its availability in Spain …

Remdesivir was the first antiviral approved for treating COVID-19. We investigated its
patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective …

Background Remdesivir is a prodrug with in vitro activity against severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Its clinical efficacy in patients with COVID-19 under …

Introduction During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir
was only approved for hospitalized patients. Our institution developed hospital‐based …

Purpose The benefits of antiviral treatment with remdesivir in hospitalized patients with
COVID-19 remain controversial. Clinical analyses are needed to demonstrate which patient …

Abstract Background and Objectives Remdesivir is an antiviral agent, which was shown to
be safe and effective in treating early COVID-19, but its favourable impact in hospitalised …

Objectives Remdesivir is one of the most widely recommended and used medications for
COVID-19 treatment. However, different outcomes have been reported for hospitalized …

Purpose This review was aimed to synthesise the best available evidence on the
effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19 …

Background. Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused
on the repurposing of available drugs to develop timely and cost-effective therapeutic …